See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Agilent Technologies, Inc. (A) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Agilent Technologies, Inc. (A) - free report >>
Image: Bigstock
New Strong Buy Stocks for July 24th
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:
Aerie Pharmaceuticals Inc : This clinical-stage pharmaceutical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.5% over the last 30 days.
Aerie Pharmaceuticals, Inc. Price and Consensus
Aerie Pharmaceuticals, Inc. Price and Consensus | Aerie Pharmaceuticals, Inc. Quote
Agilent Technologies Inc (A - Free Report) : This provider of application focused solutions has seen the Zacks Consensus Estimate for its current year earnings improving 0.1% over the last 30 days.
Agilent Technologies, Inc. Price and Consensus
Agilent Technologies, Inc. Price and Consensus | Agilent Technologies, Inc. Quote
Avista Corp (AVA - Free Report) : This electric and natural gas utility company has witnessed the Zacks Consensus Estimate for its current year earnings advancing 0.7% over the last 30 days.
Avista Corporation Price and Consensus
Avista Corporation Price and Consensus | Avista Corporation Quote
Chemours Co (CC - Free Report) : This provider of performance chemicals has seen the Zacks Consensus Estimate for its current year earnings surging 4.5% over the last 30 days.
Chemours Company (The) Price and Consensus
Chemours Company (The) Price and Consensus | Chemours Company (The) Quote
Cryolife Inc : This medical device manufacturer and processor has witnessed the Zacks Consensus Estimate for its current year earnings improving 2.4% over the last 30 days.
CryoLife, Inc. Price and Consensus
CryoLife, Inc. Price and Consensus | CryoLife, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here
Will You Make a Fortune on the Shift to Electric Cars?
Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.
With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.
It's not the one you think.
See This Ticker Free >>